Using pulmonary vein diameters for prescribing diuretic therapy and estimating its effectiveness in heart failure with preserved ejection fraction outpatients

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. McDonagh TA, Metra M, Adamo M et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 42(36), 3599–3726 (2021). •• The latest recommendations for the diagnosis and treatment of heart failure, which contain recommendations for the prescription of diuretics and evaluation of the effectiveness of diuretic therapy.
  Medline CASGoogle Scholar
• 2. Arutyunov AG, Rylova AK, Arutyunov GP. Registry of hospitalized patients with decompensated circulation (“Pavlov's hospital registr”). Report 2. Clinical significance and prognostic role of some parameters determined during physical and instrumental examination of patients with decompensated circulation. Russ. Heart Fail. J. 15(2), 67–75 (2014).
  Google Scholar
• 3. Gheorghiade M, Vaduganathan M, Fonarow GC, Bonow RO. Rehospitalization for heart failure: problems and perspectives. J. Am. Coll. Cardiol. 61(4), 391–403 (2013). • The control of drug therapy by pressure monitoring was more effective for reducing the number of hospitalizations than managing only the patient's clinical signs or symptoms.
  MedlineGoogle Scholar
• 4. Sato N, Kajimoto K, Asai K et al. Acute decompensated heart failure syndromes (ATTEND) registry. A prospective observational multicenter cohort study: rationale, design, and preliminary data. Am. Heart J. 159(6), 949–955 (2010).
  MedlineGoogle Scholar
• 5. Javaloyes P, Miró Ò, Gil V et al. ICA-SEMES Research Group clinical phenotypes of acute heart failure based on signs and symptoms of perfusion and congestion at emergency department presentation and their relationship with patient management and outcomes. Eur. J. Heart Fail. 21(11), 1353–1365 (2019).
  MedlineGoogle Scholar
• 6. Fomin IV. Chronic heart failure in Russian Federation: what do we know and what to do. Russ. J. Cardiol. 8(136), 7–13 (2016).
  Google Scholar
• 7. Belenkov YUN, Mareev VYU, Ageev FT et al. The true prevalence of CHF in the European part of the Russian Federation (hospital stage). Russ. Heart Fail. J. 12(2), 63–68 (2011).
  Google Scholar
• 8. Mullens W, Damman K, Harjola VP et al. The use of diuretics in heart failure with congestion – a position statement from the Heart Failure Association of the European Society of Cardiology. Eur. J. of Heart Fail. 21, 137–155 (2019). •• The use of diuretics in heart failure with congestion and evaluation of congestion and clinical euvolemia.
  MedlineGoogle Scholar
• 9. Abraham WT, Fonarow GC, Albert NM et al. Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). J. Am. Coll. Cardiol. 52(5), 347–356 (2008).
  MedlineGoogle Scholar
• 10. Gheorghiade M, De Luca L, Fonarow GC, Filippatos G, Metra M, Francis GS. Pathophysiologic targets in the early phase of acute heart failure syndromes. Am. J. Cardiol. 96(6A), 11G–17G (2005).
  MedlineGoogle Scholar
• 11. Lala AG, McNulty SE, Mentz RJ et al. Relief and recurrence of congestion during and after hospitalization for acute heart failure: insights from Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF). Circ. Heart Fail. 8, 741–748 (2015).
  MedlineGoogle Scholar
• 12. Martens P, Verbrugge FH, Boonen L, Nijst P, Dupont M, Mullens W. Value of routine investigations to predict loop diuretic down-titration success in stable heart failure. Int. J. Cardiol. 250, 171–175 (2018). • Shows predictive ability to detect patients with down-titration success/failure by routine diagnostics, such as physical examination (diastolic function, right ventricular function, cardiac filling pressures and valvular disease) or blood samples (serum creatinine, plasma N-terminal pro-B-type natriuretic peptide and neurohormones).
  MedlineGoogle Scholar
• 13. Costanzo MR, Stevenson LW, Adamson PB et al. Interventions linked to decreased heart failure hospitalizations during ambulatory pulmonary artery pressure monitoring. JACC Heart Fail. 4, 333–344 (2016).
  MedlineGoogle Scholar
• 14. Felker GM, Ellison DH, Mullens W, Cox ZL, Testani JM. Diuretic therapy for patients with heart failure. J. Am. Coll. Cardiol. 75(10), 1178–1195 (2020).
  Medline CASGoogle Scholar
• 15. Kirillova VV, Smorgon AV, Garganeeva AA et al. Ultrasound diagnosis of congestion in the pulmonary and systemic circulations in patients with atrial fibrillation and chronic heart failure. Russ. Open Med. J. 10, e0415 (2021).
  Google Scholar
• 16. Kirillova VV. Early ultrasound diagnostic venous pulmonaryhypertension. Eur. J. Heart Fail. 19(Suppl. 1), 496 (2017).
  Google Scholar
• 17. Kirillova VV. Fluid retention in the pulmonary circulation as a cause of pulmonary vein dilatation and atrial fibrillation development in chronic heart failure patients. Russ. Open Med. J. 11, e0121 (2022).
  CASGoogle Scholar
• 18. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am. J. Cardiol. 82(8A), 2N–9N (1998).
  Medline CASGoogle Scholar
• 19. Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circ. J. 89(2), 724–730 (1994).
  Medline CASGoogle Scholar
• 20. Haïssaguerre M, Jaïs P, Shah DC et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N. Engl. J. Med. 339(10), 659–666 (1998).
  Medline CASGoogle Scholar
• 21. Wylie JV, Peters DC, Essebag V, Manning WJ, Josephson ME, Hauser TH. Left atrial function and scar after catheter ablation of atrial fibrillation. Heart Rhythm 5(5), 656–662 (2008).
  MedlineGoogle Scholar
• 22. Shin SH. What does left atrial structural remodeling mean in cardiac resynchronization therapy? Korean J. Intern. Med. 35(5), 1070–1071 (2020).
  MedlineGoogle Scholar
• 23. Tsang TSM, Barnes ME, Abhayaratna WP et al. Effects of quinapril on left atrial structural remodeling and arterial stiffness. Am. J. Cardiol. 97(6), 916–920 (2006).
  Medline CASGoogle Scholar
• 24. Mentz RJ, Buggey J, Fiuzat M et al. Torsemide versus furosemide in heart failure patients: insights from Duke University Hospital. J. Cardiovasc. Pharmacol. 65(5), 438–443 (2015).
  Medline CASGoogle Scholar
• 25. Buggey J, Mentz RJ, Pitt B et al. A reappraisal of loop diuretic choice in heart failure patients. Am. Heart J. 169(3), 323–333 (2015).
  Medline CASGoogle Scholar
• 26. Mamcarz A, Filipiak KJJ, Drożdż J et al. Loop diuretics: old and new ones – which one to choose in clinical practice? Experts’ group consensus endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy and Working Group on Heart Failure. Kardiol. Pol. 73(3), 225–232 (2015). • Current clinical recommendations suggest beneficial effects of torasemide.
  MedlineGoogle Scholar
• 27. Balsam P, Ozierański K, Marchel M, Gawałko M, Niedziela Ł, Tymińska A. Comparative effectiveness of torasemide versus furosemide in symptomatic therapy in heart failure patients: preliminary results from the randomized TORNADO trial. Cardiol. J. 26(6), 661–668 (2019).
  MedlineGoogle Scholar
• 28. Han LN, Guo SL, Lin XM et al. Torasemide reduces dilated cardiomyopathy, complication of arrhythmia, and progression to heart failure. Genet. Mol. Res. 13(3), 7262–7274 (2014). • Torasemide reduces the left ventricular end-diastolic diameter and the number of arrythmias in patients with dilatated cardiomyopathy.
  Medline CASGoogle Scholar
• 29. Walker HKHall WDHurst JW (Eds). Clinical Methods: The History, Physical, and Laboratory Examinations (3rd Edition). Butterworths, Boston, MA, USA (1990).
  Google Scholar
• 30. Fomin IV, Kraiem N, Polyakov DS et al. The notion of CHF course stability: is it acceptable for Russian practice? Kardiol. 58(Suppl. 3), S55–S63 (2018).
  Google Scholar
• 31. Anker SD, Ponikowski P, Varney S et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 349(9058), 1050–1053 (1997).
  Medline CASGoogle Scholar
• 32. Sharpe N, Doughty R. Epidemiology of heart failure and ventricular dysfunction. Lancet 352(Suppl. 1), SI3–SI7 (1998).
  MedlineGoogle Scholar
• 33. Skowerski M, Wozniak-Skowerska I, Hoffmann A et al. Pulmonary vein anatomy variants as a biomarker of atrial fibrillation – CT angiography evaluation. BMC Cardiovasc. Disord. 18, 146 (2018).
  Medline CASGoogle Scholar
• 34. Redeker NS, Adams L, Berkowitz R et al. Nocturia, sleep and daytime function in stable heart failure. J. Card. Fail. 18(7), 569–575 (2012).
  MedlineGoogle Scholar
• 35. Hayashi T, Morita Y, Mitani H et al. Burden of heart failure on patient daily life and patient-physician discordance in disease management – results from a cross-sectional survey in Japan. Circ. Rep. 2(12), 722–729 (2020).
  MedlineGoogle Scholar
• 36. Çoner A, Özyıldız AG. Pheochromocytoma: an overlooked reversible cause of heart failure with reduced ejection fraction. Turk. Kardiyol. Dern. Ars. 49(6), 501–505 (2021).
  MedlineGoogle Scholar
• 37. Satendra M, Jesus C, Bordalo AL et al. Reversible catecholamine-induced cardiomyopathy due to pheochromocytoma: case report. Rev. Port Cardiol. 33(3), 177.e1-6 (2014).
  MedlineGoogle Scholar
• 38. Madamanchi C, Alhosaini H, Sumida A et al. Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure. Int. J. Cardiol. 176, 611–617 (2014).
  MedlineGoogle Scholar
• 39. Kirillova VV, Sokolova LA, Meshchaninov VN et al. The level of NT-proBNP in ambulatory patients with chronic heart failure with preserved ejection fraction of the left ventricle. Ter. Arkh. 9, 68–72 (2018).
  Google Scholar
• 40. Obokata M, Kane GC, Reddy YNV et al. Role of diastolic stress testing in the evaluation for heart failure with preserved ejection fraction. Circ. J. 135, 825–838 (2017).
  MedlineGoogle Scholar